Effective Training Practices for FDA Compliance

No or inadequate training of employees is one of most frequently cited deviations in FDA inspectional observations and warning letters. Trainings are either not planned, not conducted, not evaluated or not documented as expected by inspectors. On the other hand it has been is estimated that about 5% of employee’s time is spent for training. So there seems to be lack of understanding on what the regulations are, their interpretations and expectations of inspectors. This seminar will give a good understanding of FDA requirements for training and provide recommendations for implementation.

For easy implementation, attendees will receive:
Primer: Successful compliance training (20 pages)
SOP: Training for GMP Compliance
SOP: Training for GxP, 21 CFR Part 11 and Computer Validation

Areas Covered in the Session :
GxP training requirements in US and EU
Most frequently cited deviations
Developing an effective training program for a company, site or department.
Developing a training plan for individual employees
Who can or should be responsible for the training program and training plans.
Most efficient training tools for different tasks.
Assessment of successful participation
The benefits of risk based training
10 Do’s and Don’ts for permanent success
Documentation of trainings for the FDA
Specific training requirements for Part 11

Who Will Benefit:
A must attend webinar for professionals in Pharmaceutical development and quality control companies, medical device industry, Manufacturers of drug substances (APIs) and Contract laboratories, Clinical Research Organizations. The teams that will benefit the most are:
Training Departments
Quality Assurance Departments
Analysts and Lab Managers
Validation Specialists
Regulatory Affairs Departments
Human resources (HR) Departments
Documentation Departments
Consultants

Dr. Ludwig Huber

Ludwig Huber, Ph.D., is the director of Labcompliance and editor of (www.labcompliance.com), the global online resource for validation and compliance. He is the author of the books “Validation and Qualification in Analytical Laboratories” and “Validation of Computerized Analytical and Networked Systems”. He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11, 21CFR Part 111 and Validation around the world. This included seminars, workshops and presentations for the US FDA, China SFDA, Korea MFDS, Singapore HSA, ISPE, Japan PDA, PIC/S and several other national health care agencies. For more information, please visit Dr.Huber’s website (www.ludwig-huber.com).

membership
  Go PRIME   🛈 $ 240 SELECT
  Personal Plan 🛈 $ 3000 SELECT
  Business Plan 🛈 $ 9000 SELECT


  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance